Sweden· SE-20190822000136
Abacavir Accord 300 mg Filmdragerad tablett
A abacavir product containing abacavir, registered in Sweden by Accord Healthcare B.V.. The same ATC class is registered in 16 of our 19 countries.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
Where it is registered
Abacavir is registered in 16 of 19 countries.
Countries holding a registration under ATC J05AF06 (abacavir), each read from that country’s own register.
- This record: Sweden, from Swedish Medical Products Agency (Sweden)
- 10 of them publish a price we can compare per daily dose
Abacavir · ATC J05AF06
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of abacavir costs, country by country.
Normalised to the WHO defined daily dose (0.6 g), the median price runs from $3.98 in France to $9.36 in Switzerland — a ×2.3 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Abacavir · price per daily dose (0.6 g)
USD · FX 28 Sept 2026
- CH Switzerland$9.36
- FR France$3.98
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Abacavir
- Manufacturer
- Accord Healthcare B.V.
- Country
- Sweden (SE)
- ATC code
- J05AF06
- ATC class
- Abacavir
- Defined daily dose
- 0.6 g, O
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20190822000136
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
131 interactions on record for abacavir.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Abacavir · interactions on record
131 records
- 4 severe
- 23 moderate
- 6 minor
- 96 info
Most severe, free to view
- LeflunomidL04AA13severe
- TeriflunomidL04AA31severe
- LeflunomideL04AK01severe
- TeriflunomideL04AK02severe
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Abacavir in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAbacavirAurobindo Pharma Limited
- SpainABACAVIR ACCORD 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGAccord Healthcare S.L.U.
- FinlandAbacavir AccordAccord Healthcare B.V.
- FranceABACAVIR ARROW 300 mg, comprimé pelliculé sécableARROW GENERIQUES
- BelgiumAbacavir Sandoz 300 mgSandoz
- NetherlandsAbacavir Accord 300 mg, filmomhulde tablettenAccord Healthcare B.V.
- PolandAbacavir AccordAccord Healthcare Polska Sp. z o.o.
- IrelandZiagen 300mg Film-coated tableViiV Healthcare BV
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Spain · Abacavir Tarbis
- Finland · Abacavir Accord
- France · Abacavir Arrow, Abacavir Sandoz
- United Kingdom (Northern Ireland) · Abacavir Milpharm, Abacavir Mylan
- Iceland · Ziagen
- Italy · Abacavir Mylan
- Liechtenstein · Ziagen
- Netherlands · Abacavir Accord, Abacavir Sandoz
- Norway · Ziagen
- Portugal · Abacavir Farmoz, Abacavir Generis
- Romania · Abacavir Aurobindo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ec9044f8-5c71-4765-a7e2-fb1eb830b95d GET /v1/drugs/ec9044f8-5c71-4765-a7e2-fb1eb830b95d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL",
"SmPC"
],
"se_npl_id": "20190822000136",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20190822000136",
"product_doc_link": "https://docetp.mpa.se/LMF/Abacavir%20Accord%20film-coated%20tablet%20SmPC_09001bee80f856c4.pdf"
}See everything about abacavir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.